Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001034726 | SCV001198019 | likely benign | Developmental and epileptic encephalopathy, 14; Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2024-01-17 | criteria provided, single submitter | clinical testing | |
New York Genome Center | RCV001034726 | SCV002025752 | uncertain significance | Developmental and epileptic encephalopathy, 14; Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2020-05-08 | criteria provided, single submitter | clinical testing | The inherited c.2201A>G (p.Asp734Gly) variant in exon 19 of 31of KCNT1 has not been reported in affected individuals in the available literature. This variant is present in gnomADat a very lowfrequency (3/31370 alleles, AF=0.00009563, 0 homozygotes) indicating it is not a common benign variant in the populations represented in this database. In silico predictors suggest this variant is Damaging(Provean; score: -4.75) and Damaging (SIFT; score: 0.0017). Given the lack of functional evidence regarding its pathogenicity, the inherited c.2201A>G (p.Asp734Gly) variant identified in the KCNT1 gene is reported as a Variant of Uncertain Significance. |
Genome- |
RCV002271164 | SCV002554796 | uncertain significance | Developmental and epileptic encephalopathy, 14 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002271165 | SCV002554797 | uncertain significance | Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2022-03-15 | criteria provided, single submitter | clinical testing |